Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 2,616 shares at $71.93 ($193K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Scheduled sale ($193k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.93 | 134 | $10K | 5.0% |
| 2 | $71.93 | 119 | $9K | 4.4% |
| 3 | $73.26 | 491 | $36K | 18.6% |
| 4 | $73.34 | 655 | $48K | 24.8% |
| 5 | $74.37 | 443 | $33K | 17.0% |
| 6 | $74.56 | 238 |
| $18K |
| 9.2% |
| 7 | $75.47 | 255 | $19K | 10.0% |
| 8 | $75.49 | 281 | $21K | 11.0% |
| Total | $73.91 avg | 2,616 | $193K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |